bioMérieux

Our latest Annual Report is available!

2024 Annual Report

From our commitment to public health to our drive for innovation and our actions to preserve the planet, this report fully captures the essence of our Company.

Access the report

News

« Always consider sepsis in the context of infection. »

Patient associations across the globe are actively engaged in promoting this critical message to both healthcare professionals and the broader public. We met with Dr Rafael Moraes from ILAS, Melissa Mead from The UK Sepsis Trust and Thomas Heymann from Sepsis Alliance to learn more about their actions.

Discover more

Swipe to discover more

bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini

bioMérieux today announces that its BIOFIRE® SPOTFIRE® R/ST Panel Mini has received U.S. FDA 510(k) clearance and CLIA waiver for the addition of Anterior Nasal Swab as a validated specimen type for this panel.

Read the press release
A new chapter in Quality Control – how USP Chapter <86> can transform approaches to endotoxin testing

Could 2025 be the year that endotoxin testing finally catches up with the 21st century? Unlike other areas of Pharmaceutical Quality Control where innovations such as data analytics and automation have driven extensive modernization, endotoxin testing has remained resolutely stuck in the past. This vital Quality Control procedure has until recently relied on outdated testing practices that require the blood of horseshoe crabs. Significantly, new authoritative standards have recently recognized alternative testing methods that can deliver the same important validation, without relying on animal-derived products. What are these new standards and what could their integration mean for the future of endotoxin testing?

Read the blog post
bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments.

Read the news

Enabling Decision-Making

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

As an antimicrobial steward

BE A GAME CHANGER

You can help sustain antibiotic efficacy for future generations with the right diagnostic tests to guide appropriate antibiotic therapy.

Discover More

In the fight against sepsis

BE A GAME CHANGER

Time is of the essence with suspected sepsis. To make rapid & accurate decisions, diagnostic is a real support. bioMérieux commits to offer a complete solution for sepsis management – from antibiotic initiation, to monitoring, to appropriate discontinuation.

Discover more

As a protector of consumer health

BE A GAME CHANGER

When you select a diagnostic partner you can trust, manufacturing safe food and beverages comes with confidence.

Discover more

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

By choosing the right partner and diagnostics solutions you can manufacture safer products, giving you confidence in the quality of your offer.

Discover more

In respiratory infections, including COVID-19

BE A GAME CHANGER

To make sure your patients don’t miss a breath, you need a partner you can count on. bioMérieux offers a comprehensive range of diagnostic tools enabling various RESPIRATORY linked infections, including primary diagnosis of SARS-CoV-2 you can rely on.

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

Hospital & Laboratory
Point of Care
Food Safety & Quality
Pharma Quality Control

VITEK^® REVEAL™

The newest addition to our Sepsis Solution, VITEK^® REVEAL™ offers fast AST results to effectively and efficiently manage bloodstream infections.

VIDAS^® KUBE™

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE^® FILMARRAY^® TORCH

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

VITEK^® MS PRIME

VITEK^® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.

BIOFIRE^® SPOTFIRE^® System

The BIOFIRE^® SPOTFIRE^® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab, a throat swab or an anterior nasal swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care and to fight AMR.

GENE-UP^®

Our real-time PCR solution simplifies workflows, decreases cross-contamination risks, and gives you rapid results that speed up critical manufacturing decisions.

GENE-UP^® TYPER

Move from test results to actionable insights and make impactful decisions within 2 hours from an isolated colony with GENE UP® TYPER. This real-time PCR assay utilizes probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence.

VIDAS KUBE close-up in a lab with technician hands preparing and handling sample

VIDAS KUBE, Food Safety and Quality, Pathogen Detection

VIDAS^® KUBE™ Automated Food Pathogens Detection

VIDAS® KUBE™’s adaptable automation helps your lab to be more productive, more accurate, and at the forefront of innovation—all-in-one simplifed platform.

TEMPO^® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your laboratory.

ENDONEXT^™Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

BIOFIRE^® Mycoplasma

BIOFIRE® Mycoplasma provides simple, accurate, and rapid in-house mycoplasma detection for use in testing raw materials, in-process samples, and final product release. We offer validation services designed to meet regulatory requirements—from documentation to comprehensive on-site support.

3P^® ENTERPRISE

Bridging the gap between standard processes and automation, 3P® ENTERPRISE transforms the future of environmental monitoring in the pharmaceutical industry. From sampling to trending, take control with an end-to-end, fully digitalized and automated workflow. Increase efficiency and ensure your products are safe and compliant with an innovative environmental monitoring system

VITEK^®MS PRIME

The VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing. 

Discover more

Our latest Annual Report is available!

2024 Annual Report

News

« Always consider sepsis in the context of infection. »

bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini

A new chapter in Quality Control – how USP Chapter <86> can transform approaches to endotoxin testing

bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

Enabling Decision-Making

As an antimicrobial steward

BE A GAME CHANGER

In the fight against sepsis

BE A GAME CHANGER

As a protector of consumer health

BE A GAME CHANGER

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

In respiratory infections, including COVID-19

BE A GAME CHANGER

VITEK® REVEAL™

VIDAS® KUBE™

BIOFIRE® FILMARRAY® TORCH

VITEK® MS PRIME

BIOFIRE® SPOTFIRE® System

BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panels

Respiratory Tract Infections

GENE-UP®

GENE-UP® TYPER

VIDAS® KUBE™ Automated Food Pathogens Detection

TEMPO® Quality Indicator Solution

ENDONEXT™ Solutions

BIOFIRE® Mycoplasma

3P® ENTERPRISE

VITEK® MS PRIME

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

VITEK^® REVEAL™

VIDAS^® KUBE™

BIOFIRE^® FILMARRAY^® TORCH

VITEK^® MS PRIME

BIOFIRE^® SPOTFIRE^® System

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

GENE-UP^®

GENE-UP^® TYPER

VIDAS^® KUBE™ Automated Food Pathogens Detection

TEMPO^® Quality Indicator Solution

ENDONEXT^™Solutions

BIOFIRE^® Mycoplasma

3P^® ENTERPRISE

VITEK^®MS PRIME